Abstract

ObjectivePostoperative neck symptoms, including pain, swelling, uncomfortable feelings during swallowing, and incision adhesion formation, are common in patients after lobectomy through the traditional middle neck approach. A new unilateral supraclavicular approach is proposed to protect the anterior cervical region and reduce related complications. The aim of this study is to investigate the efficacy, safety, and advantages of the supraclavicular approach in lobectomy for unilateral papillary thyroid microcarcinoma (PTMC).MethodsTwo hundred sixty-three patients were recruited into either a conventional middle group (CM) or a new supraclavicular (NS) group. Clinicopathological features, surgically related variables, and postoperative symptoms were recorded. Quality of life (QOL) of all patients was assessed by the 12-item short-form health survey (SF-12) and thyroid cancer-specific QOL (THYCA-QoL) questionnaire in 3 and 12 months.ResultsThere were no statistically significant differences in clinicopathological features (including sex, age, multifocality, extrathyroidal extension, histological variants, largest tumor diameter, Hashimoto’s thyroiditis, metastasized central lymph node, removed central lymph node, surgeon, BRAF mutation, and follow-up duration), hospitalization (including hospital cost, surgery time, and blood loss during surgery), and complications between the two groups. Patients who underwent lobectomy through the NS approach had significantly better SF-12 physical, mental, and THYCA-QoL than the CM group patients in both 3 and 12 months (all p < 0.001). Moreover, the NS group had a shorter hospitalization time.ConclusionIn conclusion, the NS approach for lobectomy is a safe and effective method for reducing postoperative symptoms and increasing QOL in patients with unilateral PTMC in both 3 and 12 months’ follow-up.

Highlights

  • The incidence rate of thyroid cancer is increasing worldwide [1, 2]

  • From November 2019 to July 2020, all unilateral papillary thyroid microcarcinoma (PTMC) patients who underwent lobectomy with unilateral central lymph node dissection (CLND) at the First Hospital of Jilin University were recommended for both CM and NS approaches at the same time

  • Patients who underwent lobectomy through the NS approach had significantly better SF-12 physical, mental, and THYCA-QoL scores than the CM group patients in both 3 and 12 months

Read more

Summary

Introduction

The rapid growth of papillary thyroid microcarcinoma (PTMC), which is defined as papillary thyroid carcinoma measuring ≤1 cm in the greatest dimension, is the main reason [3]. The majority of PTMC patients have no clinical symptoms upon routine ultrasound (US) examination. The development and popularization of high-frequency US and fine-needle aspiration (FNA) have further increased the diagnosis of PTMC [4]. The recurrence rate is 1%–5%, and the 10-year mortality rate is as low as 0.3% [5]. Active surveillance (AS) is recommended as an alternative treatment choice for low-risk PTMC cases [6]. Surgery is still the mainstay for the treatment of PTMC in many countries

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call